(Q48454367)

11 February 2018

title

Serum insulin-like growth factor I regulates brain amyloid-beta levels. (English)

1 reference

11 February 2018

1 reference

1

1 reference

11 February 2018

Derek LeRoith

series ordinal

4

object named as

LeRoith D

1 reference

11 February 2018

Trejo JL

2

1 reference

11 February 2018

Gomez-Isla T

series ordinal

3

1 reference

11 February 2018

Torres-Aleman I

series ordinal

5

1 reference

11 February 2018

language of work or name

English

0 references

publication date

4 November 2002

1 reference

11 February 2018

published in

Nature Medicine

1 reference

11 February 2018

volume

8

1 reference

11 February 2018

page(s)

1390-1397

1 reference

11 February 2018

issue

12

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1038/nm1202-793

exact match

0 references

cites work

Normal growth and development in the absence of hepatic insulin-like growth factor I

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Insulin-Like growth factor I: implications in aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Neurodegeneration is associated to changes in serum insulin-like growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Decreased plasma insulin-like growth factor-I level in familial Alzheimer's disease patients carrying the Swedish APP 670/671 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Clearing the brain's amyloid cobwebs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

The cell biology of the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Localization of insulin-like growth factor binding protein-2 messenger RNA during postnatal brain development: correlation with insulin-like growth factors I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Amyloid beta peptide levels and its effects on hippocampal acetylcholine release in aged, cognitively-impaired and -unimpaired rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Cubilin, a multifunctional epithelial receptor: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

RETRACTED: A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Aging and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Insulin-like growth factor-1 ameliorates age-related behavioral deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

A conserved regulatory system for aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Glycoprotein 330/megalin (LRP-2) has low prevalence as mRNA and protein in brain microvessels and choroid plexus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Transthyretin mutations in hyperthyroxinemia and amyloid diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Serum amyloid A protein, albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

Circulating insulin-like growth factor I mediates effects of exercise on the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

7 January 2021

Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

7 January 2021

Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

7 January 2021

Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

7 January 2021

Aging as a major risk for degenerative diseases of the central nervous system.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

7 January 2021

Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

7 January 2021

Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

7 January 2021

Insulin-like growth factor I (IGF-I) protects cells from apoptosis by Alzheimer's V642I mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein-sensitive manner.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

7 January 2021

Gene-expression profile of the ageing brain in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

7 January 2021

Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

7 January 2021

Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets?

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

7 January 2021

Brain-blood permeability: TNF-alpha promotes escape of protein tracer from CSF to blood

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

7 January 2021

Insulin-like growth factor-I stimulates dephosphorylation of ikappa B through the serine phosphatase calcineurin (protein phosphatase 2B)

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

7 January 2021

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNM1202-793

7 January 2021

Identifiers

DOI

10.1038/NM1202-793

1 reference

11 February 2018

PubMed ID

12415260

1 reference

11 February 2018